24
FEATURE:
A
DEPARTMENTS
ACORDA THERAPEUTICS
6
8
10
"In my view, the leaders of our industry have not
spent enough time educating the public as to the value
innovative medicines bring to society," says Ron Cohen,
M.D., CEO of Acorda Therapeutics.
14
16
20
46
50
November 2013
CONTENTS
Welcome to
Life Science Leader
54
58
62
30
38
42
64
PUBLIC-PRIVATE
PARTNERSHIPS
SCIENCE AND
RELIGION
RARE DISEASE
DRUG DEVELOPMENT
66
How NeoStem was able to collaborate
successfully with the Vatican to advance
adult stem cell research
CSL Behring executives explain how to
compete in this emerging field.
Lilly's global head of science and
technology partnerships discusses the
company's partnerships approach.
BRAND
Editor's Note
Editorial Board/Ask The Board
Capitol Perspectives
The Disaster Of Obamacare
Companies To Watch
Vivaldi Biosciences
Outsourcing Insights
Emerging Market Outsourcing
Bio Innovation Notes
Stainless-Steel Bioprocessing
Pharma Business
Brand Protection
Finance & Bus. Development
Crowdfunding
Information Technology
Data Mining
Biopharm Dev. & Manufacturing
Launching A Biotech
Industry Leader
What Drives Innovation?
Industry Leader
QbD In Clinical Trials
Leadership Lessons
Preventing Culture Clash
@RFWrightLSL
linkedin.com/in/robertfwright
pinterest.com/rfwrightlsl
facebook.com/LifeScienceLeader
4
LifeScienceLeader.com
November 2013